Ukraine has adopted the new law on pharmaceuticals (“Law“) that fundamentally changes the regulatory framework for pharmaceuticals. The Law is largely based on EU laws, although certain provisions, including as regards parallel importation of pharmaceuticals and regulatory data protection, are not aligned with EU laws and may create hurdles for companies operating in the Ukrainian market. The Law will be enacted within 2.5 years after the expiry/lifting of martial law.
In this video, we present these and other important changes that were introduced into Ukrainian healthcare regulations by the Law, its key implementation milestones and recommend actions to be undertaken to get prepared. 

Click here to watch the video: New pharmaceuticals law to be enacted post-war

Click here to download this information in a format of infographics.

If you have any questions, please contact:

Olha Demianiuk

Olha Sviatenka

Baker & McKenzie International is a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a “partner” means a person who is a partner or equivalent in such a law firm. Similarly, reference to an “office” means an office of any such law firm. This communication has been prepared for the general information of clients and professional associates of Baker & McKenzie. You should not rely on the contents. It is not legal advice and should not be regarded as a substitute for legal advice. This may qualify as “Attorney Advertising” requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.


Olha Demianiuk is a partner in Baker McKenzie Switzerland Corporate M&A team and is the head of the Swiss Healthcare & Life Sciences Industry Group.


Olha Sviatenka can be reached at